Selected research
Industry Research
Exportin 1 Industry Research Report 2026
Market perspective
The global Exportin 1 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Exportin 1 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Exportin 1 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Exportin 1 include Biogen Inc, CanBas Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc, Wigen Biomedicine Technology (Shanghai) Co Ltd and Jiangsu Carephar Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Exportin 1 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exportin 1 Market by Company
Biogen Inc
CanBas Co Ltd
Karyopharm Therapeutics Inc
Oita University Institute of Advanced Medicine Inc
Wigen Biomedicine Technology (Shanghai) Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Exportin 1 Segment by Type
Chromosome Region Maintenance 1 Protein Homolog
XPO1
Exportin 1 Segment by Application
Oncology
Central Nervous System
Genetic Disorders
Immunology
Infectious Disease
Exportin 1 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exportin 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exportin 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exportin 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Exportin 1 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Exportin 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chromosome Region Maintenance 1 Protein Homolog
- XPO1
Applications
- Oncology
- Central Nervous System
- Genetic Disorders
- Immunology
- Infectious Disease
Companies covered
- Biogen Inc
- CanBas Co Ltd
- Karyopharm Therapeutics Inc
- Oita University Institute of Advanced Medicine Inc
- Wigen Biomedicine Technology (Shanghai) Co Ltd
- Jiangsu Carephar Pharmaceutical Co Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Exportin 1 Market Size (2021-2032)
- 2.2.2 Global Exportin 1 Sales (2021-2032)
- 2.2.3 Global Exportin 1 Market Average Price (2021-2032)
- 2.3 Exportin 1 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chromosome Region Maintenance 1 Protein Homolog
- 2.3.3 XPO1
- 2.4 Exportin 1 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncology
- 2.4.3 Central Nervous System
- 2.4.4 Genetic Disorders
- 2.4.5 Immunology
- 2.4.6 Infectious Disease
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Exportin 1 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Exportin 1 Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Exportin 1 Revenue of Manufacturers (2021-2026)
- 3.4 Global Exportin 1 Average Price by Manufacturers (2021-2026)
- 3.5 Global Exportin 1 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Exportin 1, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Exportin 1, Product Type & Application
- 3.8 Global Manufacturers of Exportin 1, Established Date
- 3.9 Global Exportin 1 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Biogen Inc
- 4.1.1 Biogen Inc Company Information
- 4.1.2 Biogen Inc Business Overview
- 4.1.3 Biogen Inc Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Biogen Inc Exportin 1 Product Portfolio
- 4.1.5 Biogen Inc Recent Developments
- 4.2 CanBas Co Ltd
- 4.2.1 CanBas Co Ltd Company Information
- 4.2.2 CanBas Co Ltd Business Overview
- 4.2.3 CanBas Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CanBas Co Ltd Exportin 1 Product Portfolio
- 4.2.5 CanBas Co Ltd Recent Developments
- 4.3 Karyopharm Therapeutics Inc
- 4.3.1 Karyopharm Therapeutics Inc Company Information
- 4.3.2 Karyopharm Therapeutics Inc Business Overview
- 4.3.3 Karyopharm Therapeutics Inc Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Karyopharm Therapeutics Inc Exportin 1 Product Portfolio
- 4.3.5 Karyopharm Therapeutics Inc Recent Developments
- 4.4 Oita University Institute of Advanced Medicine Inc
- 4.4.1 Oita University Institute of Advanced Medicine Inc Company Information
- 4.4.2 Oita University Institute of Advanced Medicine Inc Business Overview
- 4.4.3 Oita University Institute of Advanced Medicine Inc Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio
- 4.4.5 Oita University Institute of Advanced Medicine Inc Recent Developments
- 4.5 Wigen Biomedicine Technology (Shanghai) Co Ltd
- 4.5.1 Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information
- 4.5.2 Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview
- 4.5.3 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio
- 4.5.5 Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments
- 4.6 Jiangsu Carephar Pharmaceutical Co Ltd
- 4.6.1 Jiangsu Carephar Pharmaceutical Co Ltd Company Information
- 4.6.2 Jiangsu Carephar Pharmaceutical Co Ltd Business Overview
- 4.6.3 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio
- 4.6.5 Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments
5 Global Exportin 1 Market Scenario by Region
- 5.1 Global Exportin 1 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Exportin 1 Sales by Region: 2021-2032
- 5.2.1 Global Exportin 1 Sales by Region: 2021-2026
- 5.2.2 Global Exportin 1 Sales by Region: 2027-2032
- 5.3 Global Exportin 1 Revenue by Region: 2021-2032
- 5.3.1 Global Exportin 1 Revenue by Region: 2021-2026
- 5.3.2 Global Exportin 1 Revenue by Region: 2027-2032
- 5.4 North America Exportin 1 Market Facts & Figures by Country
- 5.4.1 North America Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Exportin 1 Sales by Country (2021-2032)
- 5.4.3 North America Exportin 1 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Exportin 1 Market Facts & Figures by Country
- 5.5.1 Europe Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Exportin 1 Sales by Country (2021-2032)
- 5.5.3 Europe Exportin 1 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Exportin 1 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Exportin 1 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Exportin 1 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Exportin 1 Market Facts & Figures by Country
- 5.7.1 South America Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Exportin 1 Sales by Country (2021-2032)
- 5.7.3 South America Exportin 1 Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Exportin 1 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Exportin 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Exportin 1 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Exportin 1 Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Exportin 1 Sales by Type (2021-2032)
- 6.1.1 Global Exportin 1 Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Exportin 1 Sales Market Share by Type (2021-2032)
- 6.2 Global Exportin 1 Revenue by Type (2021-2032)
- 6.2.1 Global Exportin 1 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Exportin 1 Revenue Market Share by Type (2021-2032)
- 6.3 Global Exportin 1 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Exportin 1 Sales by Application (2021-2032)
- 7.1.1 Global Exportin 1 Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Exportin 1 Sales Market Share by Application (2021-2032)
- 7.2 Global Exportin 1 Revenue by Application (2021-2032)
- 7.2.1 Global Exportin 1 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Exportin 1 Revenue Market Share by Application (2021-2032)
- 7.3 Global Exportin 1 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Exportin 1 Value Chain Analysis
- 8.1.1 Exportin 1 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Exportin 1 Production Mode & Process
- 8.2 Exportin 1 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Exportin 1 Distributors
- 8.2.3 Exportin 1 Customers
9 Global Exportin 1 Analyzing Market Dynamics
- 9.1 Exportin 1 Industry Trends
- 9.2 Exportin 1 Industry Drivers
- 9.3 Exportin 1 Industry Opportunities and Challenges
- 9.4 Exportin 1 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst